Head-to-head comparison of FOLFIRINOX versus gemcitabine plus nab-paclitaxel in advanced pancreatic cancer: a target trial emulation using real-world data.
第一作者:
Devon J,Boyne
第一单位:
Oncology Outcomes Research Initiative, University of Calgary, Alberta, Canada; Department of Oncology, Cumming School of Medicine, University of Calgary, Alberta, Canada; Division of Real World and Advanced Analytics, Cytel, Toronto, Canada. Electronic address: devon.boyne1@ucalgary.ca.
作者:
主题词
人类(Humans);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);脱氧胞苷(Deoxycytidine);氟尿嘧啶(Fluorouracil);醛氢叶酸(Leucovorin);胰腺肿瘤(Pancreatic Neoplasms)
DOI
10.1016/j.annepidem.2022.12.005
PMID
36563766
发布时间
2023-02-23
- 浏览0
Annals of epidemiology
28-34页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



